Drug manufacturing

More than 70 new advanced therapy medicinal products could be available in the UK by 2024

As many as 72 new advanced therapy medicinal products could be available in the UK by 2024, according to horizon scanning by the NHS Specialist Pharmacy Service.…

Accord’s phenytoin sodium 100mg capsules out of stock until early May 2020

The pharmaceutical manufacturer Accord has said that its phenytoin sodium NRIM 100mg capsules, used for the management of epilepsy, will be out of stock until early May 2020.…

HRT products to return earlier than expected

Supplies of some hormone replacement therapies will be resupplied earlier than expected, following a decision to fast-track their manufacture.…

Barcode database errors could see wrong medicines dispensed to patients, warns pharmacy negotiator

Pharmacists have been asked to “remain vigilant” when dispensing certain packs of medicines after a discrepancy was found between barcodes on the packs and corresponding data stored in an NHS Business Services Authority database.…

EMA tells drug manufacturers to test for probable carcinogen

The European Medicines Agency has told drug manufacturers to test all medicines that contain chemically synthesised active substances for the presence of nitrosamines.…

India and China spark concerns for UK drug supplies

Recent regulatory breaches at drug manufacturing sites in India and China have raised questions about whether the UK needs to repatriate production of critical medicines. …

One in three generic manufacturers opt to arrange their own no-deal Brexit ferry transport

A third of manufacturers affiliated with the British Generic Manufacturers Association have opted not to rely on government-run ferries after a no-deal Brexit, instead paying for their own transportation between the EU and the UK.…

Generics manufacturer Bristol Laboratories regains full good manufacturing practice status

Generics manufacturer Bristol Laboratories’ good manufacturing practice status has been fully restored, the company has announced. …

Substandard and falsified medicines: global and local efforts to address a growing problem

Substandard and falsified medicines pose a risk to public health all around the world.…

CMA warns drug companies against using discount schemes to maintain market dominance

The Competition and Markets Authority has warned drug companies against using anti-competitive discount schemes to protect dominant market position, after investigating discounts offered by the company that manufactures Remicade.…